Control of beta-cell propagation for diabetes treatment

Projektinformationen

BETACELLTREAT

ID Finanzhilfevereinbarung: QLK3-CT-2000-60023

Startdatum 23 April 2001

Enddatum 22 April 2005

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 124 596,00

EU-Beitrag € 124 596,00

Koordiniert durch

NOVO-NORDISK A/S
Denmark

Ziel

1) Expansion of recently identified fatal or adult pancreatic endocrine stem cell.
2. Maturation of expanded precursor cells into functional glucose-sensitive, insulin producing beta cells.

Wissenschaftliches Gebiet

• medical and health sciences › clinical medicine › endocrinology › diabetes
• medical and health sciences › medical biotechnology › cells technologies › stem cells

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-3. - Key action The "Cell factory"

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

BUR - Bursaries, grants, fellowships

Koordinator

NOVO-NORDISK A/S

• EU-Beitrag: Keine Daten
• Adresse: Niels Steensensvej 6 ; 2820 GENTOFFE ; Dänemark
• Gesamtkosten: Keine Daten